Prochimir SAS has been acquired by Arkema
The management of Prochimir SAS and CM-CIC Investissement have sold the company to Bostik, a subsidiary of Arkema.
Prochimir specializes in the development, design, production and distribution of technical films dedicated to the automotive, building, healthcare and clothing industries. With 65 employees, the firm's exports represent over 75% of its turnover.
Arkema is a global manufacturer in specialty chemicals and advanced materials, with three business segments: high performance materials, industrial specialties, and coating solutions. Its brands are ranked among the leaders in the markets they serve. Reporting annual sales of US$9.6 billion in 2018, the group employs around 20,000 people worldwide and operates in some 55 countries.
CM-CIC Investissement is the equity financing arm of Crédit Mutuel Alliance Fédérale. The firm supports businesses at all stages of their development and offers a wide range of services, including minority investments in technology venture capital deals, leveraged buy-outs of majority stakes and growth capital transactions.
Oaklins' team in France assisted the sellers in this transaction.
”
Vianney Lescroart
President, Prochimir SAS
Talk to the deal team
Related deals
Sunlight Group has acquired a 51% stake in Lehmann Marine GmbH
Through its acquisition of a 51% stake in Lehmann Marine GmbH, Sunlight Group continues to strengthen its position in the growing energy solutions market, while expanding its portfolio of innovative technologies. With over 30 years of expertise in producing lead-acid and lithium-ion batteries, Sunlight Group has established itself as a leader in advanced battery technology.
Learn moreDen Berk Délice accelerates growth through strategic partnership
Den Berk Délice, a leading Belgian grower of specialty tomatoes, has entered a strategic partnership with Egeria, an independent investment firm, to realize its next growth phase.
Learn moreXiel Limited has been acquired by MIS Healthcare
MIS Healthcare, a leading distributor in medical imaging, has successfully acquired Xiel Limited. This strategic acquisition merges MIS Healthcare’s extensive radiotherapy portfolio with Xiel’s specialized expertise in nuclear medicine, radiotherapy and diagnostic radiology. The merger strengthens both companies’ positions in the rapidly growing fields of oncology and nuclear medicine, promising to deliver exceptional value to the healthcare community in the UK and Ireland.
Learn more